Dr. Daniel E. McGuire, MD

Dr. McGuire practices at Gastro Health in Boynton Beach, Florida.

Dr. McGuire's NPI, 1205869526, was assigned on July 9, 2006. Dr. McGuire graduated from Lewis Katz School of Medicine in 1988. Dr. McGuire holds Florida license ME68899.

Dr. McGuire's primary practice is Gastro Health, at 7270 Boynton Beach Blvd, Boynton Beach, FL 33437 in Palm Beach County. The practice phone is (954) 433-5900.

Dr. McGuire's primary practice is Gastro Health in Boynton Beach, Florida. Dr. McGuire is also affiliated with Bethesda Hospital East. The medical group on file is Gastro Health. Dmand AI also links Dr. McGuire to 2 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGuire practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. McGuire's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. McGuire is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. McGuire's licenses on file in 4 states: Florida, Maine, New Jersey and Illinois.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. McGuire treats.

CMS data shows 2,938 Medicare services from Dr. McGuire across 18 procedure codes in 2024, for 1,431 Medicare patients. Medicare paid $317,727 for them.

CMS counts 1,431 Medicare patients who saw Dr. McGuire in 2024. The largest group is 75 to 84, with 760 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McGuire's median patient age at 76, with 56% women.

In 2024, Dr. McGuire wrote 2,872 Medicare Part D claims for 1,003 patients. 85% of them were for generic drugs. CMS names the drug for 2,699 of them, across 30 drugs with 11 or more claims each, at $717,799 in total drug cost. In 2023, CMS named 2,741 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. McGuire for performance year 2024, reported as part of a group. Dr. McGuire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGuire as offering telehealth. CMS counts 438 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. McGuire, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. McGuire in 2019.

CMS Open Payments shows 734 general payments to Dr. McGuire from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $3,643.

Dmand AI lists 3 awards for Dr. McGuire, most recently Regional Top Doctor in 2014.

Dr. McGuire graduated from Lewis Katz School of Medicine in 1988. Dr. McGuire is a member of ACG and ACP.

Dr. McGuire is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.